1-8 of 8
Sandhya Sapra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An exploratory analysis of health-related quality of life measures with belantamab mafodotin in combination with pomalidomide and dexamethasone (BPd) in patients with relapsed or refractory multiple myeloma (RRMM) enrolled in dreamm-8

Free
Paul Richardson, Craig Cole, Angely Loubert, Laurine Bunod, Manal M'Hari, Pralay Mukhopadhyay, Sandhya Sapra, Molly Purser, Benga Kazeem, Farrah Pompilus, Sagar Lonial
Journal: Blood
Blood (2025) 146 (Supplement 1): 2284.
https://doi.org/10.1182/blood-2025-2284
Published: 2025
Journal Articles

Patient-reported outcomes from dreamm-7 and dreamm-8 using the EQ-5D-3L, patient global impression of severity, and patient global impression of change

Free
Suzanne Trudel, Vania Hungria, María-Victoria Mateos, Chee Paul Lin, Julie Byrne, James Parker, Molly Purser, Sandhya Sapra, Farrah Pompilus, Sumita Roy-Ghanta, Giulia Fulci, Joanna Opalinska, Neal Sule, Brandon Kremer, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 5823.
https://doi.org/10.1182/blood-2025-5823
Published: 2025
Journal Articles

Life-years and quality-adjusted life-years with belantamab mafodotin, bortezomib, and dexamethasone vs alternative regimens in patients with Relapsed/Refractory multiple myeloma who received ≥1 prior line of therapy

Free
Attaya Suvannasankha, Benga Kazeem, Paul MacLeod, Ewa Dlotko, Natalie Boytsov, Yevgeniy Samyshkin, Simon McNamara, Molly Purser, Sandhya Sapra, Martin Kaiser
Journal: Blood
Blood (2025) 146 (Supplement 1): 4041.
https://doi.org/10.1182/blood-2025-4041
Published: 2025
Journal Articles

Health-related quality of life with belantamab mafodotin in patients with relapsed or refractory multiple myeloma (RRMM): An exploratory analysis of overall quality of life in dreamm-7

Free
Sagar Lonial, Craig Cole, Angely Loubert, Laurine Bunod, Manal M'Hari, Pralay Mukhopadhyay, Sandhya Sapra, Molly Purser, Jacqueline Nielsen, Benga Kazeem, Farrah Pompilus, Paul Richardson
Journal: Blood
Blood (2025) 146 (Supplement 1): 4029.
https://doi.org/10.1182/blood-2025-4029
Published: 2025
Journal Articles

Years of life lost to multiple myeloma remains high: A targeted literature review

Free
Roberto Mina, Amruta Radhakrishnan, Anupama Vasudevan, Sandhya Sapra, Alex Bates, James Parker, Joshua Richter
Journal: Blood
Blood (2025) 146 (Supplement 1): 2804.
https://doi.org/10.1182/blood-2025-2804
Published: 2025
Journal Articles

Effectiveness and Safety of Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma in Real-Life Setting: The ALFA Study

Free
Murielle Roussel, Nathalie Texier, Raphaël Germain, Sandhya Sapra, Prani Paka, Naima Kerbouche, Xavier Colin, Xavier Leleu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4261–4263.
https://doi.org/10.1182/blood-2022-156035
Published: 2022
Journal Articles

DREAMM-2: Single-Agent Belantamab Mafodotin (Belamaf) Effects on Patient-Reported Outcome (PRO) Measures in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Free
Rakesh Popat, Sagar Lonial, MD FACP, Peter M. Voorhees, MD, Simona Degli Esposti, MD, Ira Gupta, MD, Joanna Opalinska, MD, Sandhya Sapra, PhD, Boris Gorsh, PharmD, Zangdong He, PhD, David M Kleinman, MD, Debra Schaumberg, OD, MPH, ScD, Angely Loubert, PharmD, MSc, Juliette Meunier, MSc, Antoine Regnault, PhD, Laurie Eliason, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140013
Published: 2020
Journal Articles

Patient-Reported Experiences during and Following Treatment with Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study

Free
Laurie Eliason, MPH, Julia Correll, MPH, Mona Martin, MPA, Anna Cardellino, MPH, Joanna Opalinska, MD, Trisha Piontek, BSN, Boris Gorsh, PharmD, Sandhya Sapra, PhD, Rakesh Popat
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-139395
Published: 2020